Development and feasibility of randomized trial to reduce urinary bisphenols in women with obesity.
Todd Alan HagobianZoe Delli-BoviAdrian MercadoAlyssa BirdMegan GuySuzanne PhelanPublished in: Pilot and feasibility studies (2021)
In women with obesity, the 3-week intervention was considered feasible with promising preliminary results of decreasing BPS concentrations. These data warrant future large-scale clinical trial interventions to reduce bisphenol exposure and determine whether reductions in bisphenols positively impact diabetes and cardiovascular disease risk markers. This study was retroactively registered at ClinicalTrial.gov Identifier NCT03440307.
Keyphrases
- cardiovascular disease
- type diabetes
- insulin resistance
- clinical trial
- metabolic syndrome
- weight loss
- high fat diet induced
- weight gain
- randomized controlled trial
- glycemic control
- physical activity
- electronic health record
- skeletal muscle
- open label
- adipose tissue
- double blind
- study protocol
- current status
- cardiovascular risk factors
- cardiovascular events
- body mass index
- phase iii